SR One is a leading global biotech venture capital firm.
We are on a mission to power the arc of innovation from science to medicine. We back brilliant teams to develop transformative medicines, from lab bench to patient bedside.
SR One takes a back-and-build approach to its investments. Focusing on companies that we believe have strong underlying fundamentals, a clearly defined development pathway, and novel approaches to addressing diseases, SR One aims to help reimagine today’s science for tomorrow’s medicines.
People
You last contacted this investor on .